(Q64071120)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31046839%20AND%20SRC:MED&resulttype=core&format=json

24 April 2020

title

Immunotherapeutic effects of intratumoral nanoplexed poly I:C (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31046839%20AND%20SRC:MED&resulttype=core&format=json

24 April 2020

0 references

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31046839%20AND%20SRC:MED&resulttype=core&format=json

24 April 2020

Pedro P López-Casas

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31046839%20AND%20SRC:MED&resulttype=core&format=json

Maria Esperanza Rodriguez-Ruiz

24 April 2020

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31046839%20AND%20SRC:MED&resulttype=core&format=json

24 April 2020

Ivan Marquez-Rodas

13

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31046839%20AND%20SRC:MED&resulttype=core&format=json

24 April 2020

Ignacio Melero Bermejo

16

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31046839%20AND%20SRC:MED&resulttype=core&format=json

24 April 2020

author name string

M Angela Aznar

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31046839%20AND%20SRC:MED&resulttype=core&format=json

24 April 2020

Lourdes Planelles

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31046839%20AND%20SRC:MED&resulttype=core&format=json

24 April 2020

Mercedes Perez-Olivares

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31046839%20AND%20SRC:MED&resulttype=core&format=json

24 April 2020

Carmen Molina

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31046839%20AND%20SRC:MED&resulttype=core&format=json

24 April 2020

Saray Garasa

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31046839%20AND%20SRC:MED&resulttype=core&format=json

24 April 2020

Guiomar Perez

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31046839%20AND%20SRC:MED&resulttype=core&format=json

24 April 2020

Inmaculada Rodriguez

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31046839%20AND%20SRC:MED&resulttype=core&format=json

24 April 2020

Elixabet Bolaños

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31046839%20AND%20SRC:MED&resulttype=core&format=json

24 April 2020

Jose L Perez-Gracia

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31046839%20AND%20SRC:MED&resulttype=core&format=json

24 April 2020

Alvaro Teijeira

14

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31046839%20AND%20SRC:MED&resulttype=core&format=json

24 April 2020

Marisol Quintero

15

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31046839%20AND%20SRC:MED&resulttype=core&format=json

24 April 2020

language of work or name

English

0 references

publication date

2 May 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31046839%20AND%20SRC:MED&resulttype=core&format=json

Journal for Immunotherapy of Cancer

24 April 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31046839%20AND%20SRC:MED&resulttype=core&format=json

24 April 2020

volume

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31046839%20AND%20SRC:MED&resulttype=core&format=json

24 April 2020

issue

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31046839%20AND%20SRC:MED&resulttype=core&format=json

24 April 2020

page(s)

116

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31046839%20AND%20SRC:MED&resulttype=core&format=json

Creative Commons Attribution 4.0 International

24 April 2020

copyright license

start time

2 May 2019

1 reference

April 2022 Public Data File from Crossref

copyright status

copyrighted

0 references

describes a project that uses

limma

1 reference

22 June 2022

https://europepmc.org/article/PMC/6498680

inferred from PubMed Central ID database lookup

cites work

A phase I study of ampligen in human immunodeficiency virus-infected subjects

1 reference

12 December 2020

Intratumoral low-dose interleukin-2 induces rejection of distant solid tumour

1 reference

12 December 2020

Differential effect of poly rI.rC and Newcastle disease virus on the expression of interferon and cellular genes in mouse cells

1 reference

12 December 2020

Prospects for the use of double-stranded ribonucleic acid (poly I:C) inducers in man.

1 reference

12 December 2020

Response of L-1210 tumor in mice toward treatment with interferon or poly(I) X poly(C).

1 reference

12 December 2020

Summaries of Affymetrix GeneChip probe level data

1 reference

12 December 2020

Bioconductor: open software development for computational biology and bioinformatics

1 reference

12 December 2020

Defining the antigen-specific T-cell response to vaccination and poly(I:C)/TLR3 signaling: evidence of enhanced primary and memory CD8 T-cell responses and antitumor immunity.

1 reference

12 December 2020

The controversial abscopal effect

1 reference

12 December 2020

The adjuvant effects of the toll-like receptor 3 ligand polyinosinic-cytidylic acid poly (I:C) on antigen-specific CD8+ T cell responses are partially dependent on NK cells with the induction of a beneficial cytokine milieu

1 reference

12 December 2020

Intratumoral injection of IL-12 plasmid DNA--results of a phase I/IB clinical trial

1 reference

12 December 2020

Toll-like receptor ligands energize peptide vaccines through multiple paths

1 reference

12 December 2020

TLR3: interferon induction by double-stranded RNA including poly(I:C).

1 reference

12 December 2020

Batf3 Deficiency Reveals a Critical Role for CD8 + Dendritic Cells in Cytotoxic T Cell Immunity

1 reference

12 December 2020

Toll-like receptor and RIG-I-like receptor signaling

1 reference

12 December 2020

Targeted activation of innate immunity for therapeutic induction of autophagy and apoptosis in melanoma cells

1 reference

12 December 2020

Self-killing of melanoma cells by cytosolic delivery of dsRNA: wiring innate immunity for a coordinated mobilization of endosomes, autophagosomes and the apoptotic machinery in tumor cells.

1 reference

12 December 2020

Type I IFN controls chikungunya virus via its action on nonhematopoietic cells

1 reference

12 December 2020

The role of pattern-recognition receptors in innate immunity: update on Toll-like receptors

1 reference

12 December 2020

In situ vaccination with a TLR9 agonist induces systemic lymphoma regression: a phase I/II study

1 reference

12 December 2020

Induction of CD8+ T-cell responses against novel glioma-associated antigen peptides and clinical activity by vaccinations with {alpha}-type 1 polarized dendritic cells and polyinosinic-polycytidylic acid stabilized by lysine and carboxymethylcellulo

1 reference

12 December 2020

Adoptive immunotherapy combined with intratumoral TLR agonist delivery eradicates established melanoma in mice

1 reference

12 December 2020

Synthetic double-stranded RNA induces innate immune responses similar to a live viral vaccine in humans

1 reference

12 December 2020

Phase I Trial of Overlapping Long Peptides from a Tumor Self-Antigen and Poly-ICLC Shows Rapid Induction of Integrated Immune Response in Ovarian Cancer Patients

1 reference

12 December 2020

Randomized dose-finding clinical trial of oncolytic immunotherapeutic vaccinia JX-594 in liver cancer

1 reference

12 December 2020

Local immunomodulation for cancer therapy: Providing treatment where needed

1 reference

12 December 2020

Intratumoral immunization: a new paradigm for cancer therapy

1 reference

12 December 2020

Therapeutic in situ autovaccination against solid cancers with intratumoral poly-ICLC: case report, hypothesis, and clinical trial

1 reference

12 December 2020

Vaccine adjuvant uses of poly-IC and derivatives

1 reference

12 December 2020

Induction of robust type-I CD8+ T-cell responses in WHO grade 2 low-grade glioma patients receiving peptide-based vaccines in combination with poly-ICLC.

1 reference

12 December 2020

limma powers differential expression analyses for RNA-sequencing and microarray studies

1 reference

12 December 2020

PolyI:C-Induced, TLR3/RIP3-Dependent Necroptosis Backs Up Immune Effector-Mediated Tumor Elimination In Vivo.

1 reference

12 December 2020

Direct Activation of STING in the Tumor Microenvironment Leads to Potent and Systemic Tumor Regression and Immunity

1 reference

12 December 2020

Talimogene Laherparepvec Improves Durable Response Rate in Patients With Advanced Melanoma

1 reference

12 December 2020

Evolving synergistic combinations of targeted immunotherapies to combat cancer.

1 reference

12 December 2020

Cancer Immunotherapy with Immunomodulatory Anti-CD137 and Anti-PD-1 Monoclonal Antibodies Requires BATF3-Dependent Dendritic Cells

1 reference

12 December 2020

In situ vaccination for the treatment of cancer.

1 reference

12 December 2020

Talimogene Laherparepvec for the Treatment of Advanced Melanoma

1 reference

12 December 2020

Abscopal Effects of Radiotherapy Are Enhanced by Combined Immunostimulatory mAbs and Are Dependent on CD8 T Cells and Crosspriming.

1 reference

12 December 2020

Immunogenic cell death in cancer and infectious disease

1 reference

12 December 2020

Intratumoral Delivery of Immunotherapy-Act Locally, Think Globally

1 reference

12 December 2020

1 reference

12 December 2020

An immunogenic personal neoantigen vaccine for patients with melanoma

1 reference

12 December 2020

Oncolytic Virotherapy Promotes Intratumoral T Cell Infiltration and Improves Anti-PD-1 Immunotherapy.

1 reference

12 December 2020

Antigen Cross-Presentation and T-Cell Cross-Priming In Cancer Immunology And Immunotherapy

1 reference

12 December 2020

Immunotherapy targeting 4-1BB: mechanistic rationale, clinical results, and future strategies

1 reference

12 December 2020

Trial watch: Immunogenic cell death induction by anticancer chemotherapeutics

1 reference

12 December 2020

Eradication of spontaneous malignancy by local immunotherapy.

1 reference

12 December 2020

Combined immunotherapy encompassing intratumoral poly-ICLC, dendritic-cell vaccination and radiotherapy in advanced cancer patients.

1 reference

12 December 2020

Cancer immunotherapy using checkpoint blockade.

1 reference

12 December 2020

10.1186/S40425-019-0568-2

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31046839%20AND%20SRC:MED&resulttype=core&format=json

24 April 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:31046839%20AND%20SRC:MED&resulttype=core&format=json

24 April 2020

PubMed publication ID

31046839

1 reference